Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Kimberly Jordan

Concepts (315)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
8
2025
586
1.360
 Why?
Tumor Microenvironment
11
2024
735
1.180
 Why?
T-Lymphocytes
11
2022
1982
1.120
 Why?
Cancer Vaccines
7
2021
160
1.120
 Why?
Myeloid-Derived Suppressor Cells
5
2023
72
1.050
 Why?
Antineoplastic Combined Chemotherapy Protocols
7
2025
1958
0.830
 Why?
Antigens, Neoplasm
6
2021
272
0.730
 Why?
Receptors, Antigen, T-Cell
7
2021
668
0.670
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.660
 Why?
Baculoviridae
3
2009
44
0.620
 Why?
Cytoreduction Surgical Procedures
1
2020
67
0.620
 Why?
Chemotherapy, Adjuvant
1
2020
421
0.580
 Why?
Image Processing, Computer-Assisted
1
2023
781
0.580
 Why?
Insecta
3
2009
74
0.560
 Why?
Neoadjuvant Therapy
2
2022
463
0.550
 Why?
Extracellular Vesicles
1
2020
171
0.540
 Why?
Melanoma
4
2023
761
0.510
 Why?
Colorectal Neoplasms
4
2025
848
0.510
 Why?
Granulocytes
1
2017
80
0.500
 Why?
Pancreatic Cyst
1
2017
50
0.480
 Why?
Lymphocyte Activation
4
2017
1126
0.480
 Why?
Monocytes
2
2020
538
0.440
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
3
2025
132
0.430
 Why?
Spleen
1
2017
508
0.430
 Why?
CD8-Positive T-Lymphocytes
7
2024
917
0.430
 Why?
Vaccines
2
2010
389
0.430
 Why?
Xenograft Model Antitumor Assays
8
2025
930
0.420
 Why?
Programmed Cell Death 1 Receptor
3
2022
264
0.420
 Why?
Myeloid Cells
2
2020
148
0.400
 Why?
Neoplasms
6
2017
2884
0.400
 Why?
Vaccines, Subunit
2
2012
53
0.390
 Why?
Tomography, X-Ray Computed
1
2023
2738
0.380
 Why?
Histone-Lysine N-Methyltransferase
2
2024
141
0.370
 Why?
Complementarity Determining Regions
1
2012
53
0.360
 Why?
Cell Line, Tumor
10
2025
3550
0.350
 Why?
Gamma Rays
2
2021
56
0.330
 Why?
Benzimidazoles
2
2024
190
0.320
 Why?
Mice, Inbred BALB C
9
2025
1253
0.320
 Why?
Mice
24
2025
18365
0.310
 Why?
Antibodies, Monoclonal, Humanized
4
2025
988
0.300
 Why?
Antineoplastic Agents, Immunological
4
2020
199
0.300
 Why?
Inflammation
1
2020
2880
0.290
 Why?
CD47 Antigen
2
2025
42
0.270
 Why?
Immunotherapy
5
2021
657
0.270
 Why?
H-2 Antigens
1
2008
111
0.270
 Why?
Breast Neoplasms
1
2020
2456
0.270
 Why?
Pancreatic Neoplasms
3
2021
927
0.260
 Why?
Antigens
1
2009
347
0.260
 Why?
Cell Proliferation
7
2024
2499
0.260
 Why?
Carcinoma, Pancreatic Ductal
2
2021
292
0.250
 Why?
Drug Resistance, Neoplasm
4
2025
883
0.250
 Why?
Proteome
2
2022
518
0.250
 Why?
Female
30
2025
78376
0.250
 Why?
Tumor Escape
2
2017
49
0.250
 Why?
Peptide Library
4
2013
95
0.250
 Why?
Peptides
4
2021
998
0.240
 Why?
Survival Analysis
4
2021
1385
0.240
 Why?
Vaccination
3
2010
1423
0.240
 Why?
Animals
27
2025
38109
0.230
 Why?
Humans
45
2025
144957
0.230
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
154
0.230
 Why?
Phthalazines
1
2025
64
0.220
 Why?
Lung Neoplasms
3
2024
2642
0.220
 Why?
Transcriptome
2
2022
1046
0.220
 Why?
Lupus Nephritis
1
2025
70
0.220
 Why?
Major Histocompatibility Complex
4
2021
229
0.220
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2025
109
0.220
 Why?
Models, Biological
2
2021
1822
0.210
 Why?
Disease Models, Animal
5
2024
4569
0.210
 Why?
Tryptophan Oxygenase
1
2024
33
0.210
 Why?
Keratins
1
2024
172
0.200
 Why?
Bevacizumab
1
2024
167
0.200
 Why?
Cystadenocarcinoma, Serous
1
2024
84
0.200
 Why?
Interferons
2
2022
188
0.200
 Why?
beta Catenin
1
2025
253
0.200
 Why?
Signal-To-Noise Ratio
1
2023
73
0.200
 Why?
Neoplasms, Experimental
2
2021
173
0.190
 Why?
Piperazines
1
2025
381
0.190
 Why?
Artifacts
1
2023
139
0.190
 Why?
Fallopian Tubes
1
2022
33
0.190
 Why?
Prognosis
5
2024
4293
0.190
 Why?
Dendritic Cells
4
2020
499
0.190
 Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1182
0.190
 Why?
Ephrin-B2
2
2021
45
0.190
 Why?
Small Cell Lung Carcinoma
1
2024
119
0.190
 Why?
Fibrosis
2
2024
548
0.180
 Why?
Neoplasms, Second Primary
1
2023
100
0.180
 Why?
Tretinoin
2
2023
124
0.180
 Why?
Flow Cytometry
5
2022
1173
0.170
 Why?
Blood
1
2022
109
0.170
 Why?
Mycosis Fungoides
1
2021
62
0.170
 Why?
Gene Expression Profiling
3
2021
1786
0.170
 Why?
ADAM10 Protein
1
2021
29
0.170
 Why?
Middle Aged
12
2025
35928
0.170
 Why?
Ovary
1
2022
228
0.170
 Why?
Precision Medicine
1
2025
458
0.170
 Why?
Synovial Membrane
1
2022
124
0.170
 Why?
Seroconversion
1
2021
49
0.160
 Why?
Amyloid Precursor Protein Secretases
1
2021
77
0.160
 Why?
Proteomics
3
2024
1195
0.160
 Why?
Oligonucleotides, Antisense
1
2020
116
0.160
 Why?
Eosinophilic Esophagitis
1
2024
330
0.160
 Why?
Databases, Genetic
1
2021
249
0.160
 Why?
Immunity
1
2020
139
0.160
 Why?
Splenectomy
1
2020
65
0.150
 Why?
Macrophages
2
2024
1511
0.150
 Why?
Radiation Injuries
1
2021
151
0.150
 Why?
Diagnostic Imaging
1
2022
339
0.150
 Why?
Cell Adhesion
1
2020
455
0.150
 Why?
Case-Control Studies
3
2022
3608
0.150
 Why?
Receptor, EphB4
1
2019
33
0.150
 Why?
Adrenal Cortex Neoplasms
1
2020
65
0.140
 Why?
Neoplasm Invasiveness
1
2020
509
0.140
 Why?
Adrenocortical Carcinoma
1
2020
67
0.140
 Why?
Epithelial-Mesenchymal Transition
1
2021
220
0.140
 Why?
T-Lymphocytes, Regulatory
3
2020
389
0.140
 Why?
STAT3 Transcription Factor
1
2020
207
0.140
 Why?
Survival Rate
2
2021
2092
0.140
 Why?
Radiosurgery
1
2022
401
0.140
 Why?
Cell Communication
1
2020
324
0.140
 Why?
Isoxazoles
1
2018
54
0.140
 Why?
Interferon-alpha
1
2019
197
0.140
 Why?
Papillomavirus Infections
1
2022
345
0.140
 Why?
Multiple Sclerosis
1
2024
484
0.140
 Why?
Ipilimumab
1
2018
40
0.140
 Why?
Autoantigens
1
2021
429
0.140
 Why?
Mice, Transgenic
3
2024
2185
0.140
 Why?
Immunophenotyping
3
2017
322
0.140
 Why?
Biomarkers, Tumor
2
2022
1322
0.140
 Why?
Antigens, CD19
1
2018
129
0.130
 Why?
Metabolome
1
2021
384
0.130
 Why?
Colonic Neoplasms
2
2012
260
0.130
 Why?
Drug Discovery
1
2018
155
0.130
 Why?
Head and Neck Neoplasms
1
2022
562
0.130
 Why?
Lymphoma, Non-Hodgkin
1
2018
124
0.130
 Why?
Combined Modality Therapy
1
2020
1268
0.130
 Why?
Histone Deacetylase Inhibitors
1
2019
220
0.130
 Why?
Adult
9
2025
40506
0.130
 Why?
Oxidation-Reduction
1
2020
1087
0.130
 Why?
Problem-Based Learning
1
2017
98
0.120
 Why?
Students, Pharmacy
1
2017
96
0.120
 Why?
Spodoptera
2
2021
40
0.120
 Why?
Disease Progression
3
2025
2852
0.120
 Why?
Cell Count
1
2017
321
0.120
 Why?
Adipose Tissue
1
2020
653
0.120
 Why?
Triple Negative Breast Neoplasms
1
2019
216
0.120
 Why?
Cytotoxicity, Immunologic
2
2020
223
0.110
 Why?
Algorithms
1
2023
1839
0.110
 Why?
Signal Transduction
4
2024
5233
0.110
 Why?
Aged
7
2025
25947
0.110
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
293
0.110
 Why?
Multiple Myeloma
1
2018
304
0.110
 Why?
Immunotherapy, Adoptive
1
2018
337
0.110
 Why?
Neoplasm Recurrence, Local
1
2021
1141
0.110
 Why?
Perception
1
2017
377
0.110
 Why?
Tumor Cells, Cultured
3
2021
919
0.110
 Why?
Membrane Proteins
1
2021
1167
0.100
 Why?
Skin Neoplasms
1
2021
847
0.100
 Why?
Mice, Nude
3
2020
688
0.100
 Why?
Liver Neoplasms
1
2020
783
0.100
 Why?
Blood Cell Count
1
2013
54
0.100
 Why?
Prostatic Neoplasms
1
2020
978
0.100
 Why?
Lipopolysaccharide Receptors
1
2013
87
0.100
 Why?
Arthritis, Rheumatoid
1
2022
1169
0.100
 Why?
Immunohistochemistry
3
2022
1718
0.100
 Why?
Male
12
2025
72406
0.090
 Why?
Interferon-gamma
2
2021
784
0.090
 Why?
Apoptosis
4
2024
2430
0.090
 Why?
Young Adult
3
2021
14126
0.090
 Why?
Down Syndrome
1
2019
534
0.090
 Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
 Why?
Epitopes, T-Lymphocyte
1
2012
175
0.090
 Why?
Cells, Cultured
2
2017
4155
0.090
 Why?
Datasets as Topic
2
2022
122
0.090
 Why?
B7-H1 Antigen
2
2024
241
0.080
 Why?
Follow-Up Studies
1
2020
5417
0.080
 Why?
Transcription Factors
1
2018
1742
0.080
 Why?
Neoplasm Proteins
1
2013
444
0.080
 Why?
Curriculum
1
2017
1060
0.080
 Why?
Immunodominant Epitopes
1
2010
27
0.080
 Why?
Biomarkers
4
2024
4275
0.080
 Why?
Neoplasm Staging
1
2013
1465
0.070
 Why?
Genes, MHC Class I
1
2009
36
0.070
 Why?
Gene Expression Regulation, Neoplastic
2
2025
1462
0.070
 Why?
Genetic Engineering
1
2009
93
0.070
 Why?
Histocompatibility Antigens Class I
1
2010
202
0.070
 Why?
Cell Survival
2
2024
1098
0.070
 Why?
Complement System Proteins
2
2022
316
0.070
 Why?
Histocompatibility Antigen H-2D
1
2008
20
0.070
 Why?
Cross-Priming
1
2008
16
0.070
 Why?
CD11c Antigen
1
2008
40
0.070
 Why?
Adjuvants, Immunologic
1
2009
245
0.070
 Why?
Molecular Targeted Therapy
2
2020
434
0.060
 Why?
RNA, Messenger
3
2024
2832
0.060
 Why?
Cell Culture Techniques
1
2009
375
0.060
 Why?
Nephrocalcinosis
1
2025
13
0.060
 Why?
Aged, 80 and over
2
2020
8279
0.060
 Why?
Gene Expression
2
2022
1490
0.060
 Why?
Microsatellite Instability
1
2025
54
0.060
 Why?
Immune Tolerance
1
2008
379
0.060
 Why?
Adolescent
2
2025
22453
0.060
 Why?
Cetuximab
1
2025
111
0.060
 Why?
Drug Synergism
1
2025
357
0.050
 Why?
Ligands
2
2022
674
0.050
 Why?
Cancer-Associated Fibroblasts
1
2024
23
0.050
 Why?
Histocompatibility Antigens
1
2024
102
0.050
 Why?
Neuroendocrine Cells
1
2024
33
0.050
 Why?
Cell Line
1
2010
2882
0.050
 Why?
Microsatellite Repeats
1
2024
157
0.050
 Why?
Neoplasm Grading
1
2024
309
0.050
 Why?
Wnt Signaling Pathway
1
2025
210
0.050
 Why?
Cell Differentiation
1
2011
2050
0.050
 Why?
Kynurenine
1
2024
114
0.050
 Why?
Recombinant Fusion Proteins
1
2025
675
0.050
 Why?
Imidazoles
1
2024
254
0.050
 Why?
Neuroendocrine Tumors
1
2024
114
0.050
 Why?
Tryptophan
1
2024
181
0.050
 Why?
Mice, Inbred C57BL
3
2021
5997
0.050
 Why?
Desmin
1
2002
24
0.050
 Why?
Myofibrils
1
2002
49
0.040
 Why?
Sf9 Cells
1
2021
11
0.040
 Why?
Autophagy
1
2024
286
0.040
 Why?
Lymphocytes
2
2020
382
0.040
 Why?
Tissue Distribution
1
2022
334
0.040
 Why?
Hypoalbuminemia
1
2021
28
0.040
 Why?
Access to Information
1
2021
48
0.040
 Why?
Cell- and Tissue-Based Therapy
1
2021
80
0.040
 Why?
Ranolazine
1
2020
25
0.040
 Why?
Animals, Genetically Modified
1
2002
250
0.040
 Why?
Carcinogenesis
1
2022
229
0.040
 Why?
Cluster Analysis
1
2022
521
0.040
 Why?
Seroepidemiologic Studies
1
2021
172
0.040
 Why?
Enzyme Inhibitors
1
2024
826
0.040
 Why?
Data Mining
1
2021
117
0.040
 Why?
Receptors, CCR
1
2020
6
0.040
 Why?
Cytokines
3
2018
2065
0.040
 Why?
Platelet Count
1
2020
96
0.040
 Why?
RNA, Viral
1
2024
688
0.040
 Why?
Basophils
1
2020
52
0.040
 Why?
Lymphocyte Subsets
1
2020
83
0.040
 Why?
Hematopoiesis
1
2021
194
0.040
 Why?
Interleukin-6
1
2024
780
0.040
 Why?
Tumor Burden
1
2020
322
0.040
 Why?
Leukocyte Count
1
2020
316
0.040
 Why?
Autoimmunity
1
2025
927
0.040
 Why?
Mutation
1
2010
4099
0.040
 Why?
Swine
1
2002
833
0.040
 Why?
Pancreaticoduodenectomy
1
2020
135
0.040
 Why?
Postoperative Period
1
2020
354
0.040
 Why?
Biological Availability
1
2018
142
0.030
 Why?
Immunoglobulin G
1
2003
893
0.030
 Why?
Automation
1
2018
102
0.030
 Why?
Killer Cells, Natural
1
2021
469
0.030
 Why?
Gene Knockdown Techniques
1
2019
336
0.030
 Why?
Radiotherapy
1
2019
206
0.030
 Why?
Complement Activation
1
2021
411
0.030
 Why?
Inpatients
1
2022
546
0.030
 Why?
Structure-Activity Relationship
1
2018
570
0.030
 Why?
Kidney
1
2025
1496
0.030
 Why?
Molecular Structure
1
2018
501
0.030
 Why?
B-Lymphocytes
1
2003
877
0.030
 Why?
Lipid Metabolism
1
2020
528
0.030
 Why?
Homeostasis
1
2021
640
0.030
 Why?
Aging
1
2008
1966
0.030
 Why?
Protein Domains
1
2018
313
0.030
 Why?
Drug Delivery Systems
1
2020
381
0.030
 Why?
Cell Movement
1
2021
965
0.030
 Why?
Administration, Oral
1
2018
848
0.030
 Why?
Comorbidity
1
2021
1660
0.030
 Why?
Education, Pharmacy
1
2017
121
0.030
 Why?
Metabolomics
1
2021
727
0.030
 Why?
Antibodies, Monoclonal
1
2022
1524
0.030
 Why?
Educational Measurement
1
2017
326
0.030
 Why?
Dose-Response Relationship, Drug
1
2018
2032
0.030
 Why?
Severity of Illness Index
1
2022
2925
0.030
 Why?
Neutrophils
1
2019
1134
0.020
 Why?
Program Evaluation
1
2017
949
0.020
 Why?
Cross Reactions
1
2012
130
0.020
 Why?
Antineoplastic Agents
1
2024
2197
0.020
 Why?
Retrospective Studies
2
2021
17101
0.020
 Why?
Muscle, Skeletal
1
2002
1796
0.020
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
55
0.020
 Why?
Culture Media, Conditioned
1
2011
111
0.020
 Why?
Endocytosis
1
2011
168
0.020
 Why?
Hospitalization
1
2021
2434
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
851
0.020
 Why?
Universities
1
2013
452
0.020
 Why?
In Vitro Techniques
1
2011
1048
0.020
 Why?
Treatment Outcome
1
2024
11695
0.020
 Why?
Prospective Studies
1
2021
7997
0.020
 Why?
Mice, Knockout
2
2008
3125
0.020
 Why?
Enterotoxins
1
2006
89
0.010
 Why?
T-Lymphocytes, Cytotoxic
1
2006
177
0.010
 Why?
Drug Design
1
2006
173
0.010
 Why?
DNA Primers
1
2006
512
0.010
 Why?
Antigen Presentation
1
2006
205
0.010
 Why?
Blood Cells
1
2003
37
0.010
 Why?
CD40 Ligand
1
2003
40
0.010
 Why?
Colorado
1
2013
4564
0.010
 Why?
Coculture Techniques
1
2003
246
0.010
 Why?
Toes
1
2002
16
0.010
 Why?
Amino Acid Sequence
1
2006
2157
0.010
 Why?
Sarcomeres
1
2002
98
0.010
 Why?
Molecular Sequence Data
1
2006
2931
0.010
 Why?
Antibody Formation
1
2003
294
0.010
 Why?
Child
1
2021
22657
0.010
 Why?
Microscopy, Electron
1
2002
415
0.010
 Why?
Immunoglobulins
1
2002
160
0.010
 Why?
Organ Size
1
2002
463
0.010
 Why?
Cattle
1
2003
1000
0.010
 Why?
Echocardiography
1
2002
652
0.010
 Why?
Birth Weight
1
2002
522
0.010
 Why?
Biomechanical Phenomena
1
2002
842
0.010
 Why?
Placenta
1
2002
780
0.010
 Why?
Phenotype
1
2002
3164
0.010
 Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (315) concept(s)
_
Co-Authors Expand Description
See all (140) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)